跳至主要内容
临床试验/IRCT138807112539N1
IRCT138807112539N1已完成3 期

A comparative evaluation of combination therapy of Lamivudine and Colchicine comparing with Lamivudine and placebo in clinical and laboratory improvement of chronic hepatitis B

Arak University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 70 years(—)
性别
All

入选标准

  • positive HBS Ag, confirmed chronic hepatitis B, ALT level at least twofold of normal range
  • Exclusion criteria: positive HCV Ab, positive HIV Ab, Alcohol abuse, Presence of auto immune hepatitis, metabolic liver disease, right cardiac failure or pulmonary hypertension, low compliance, allergic reaction to drugs or sever side effect of drugs, presence of decompensate cirrhosis (PT>20 sec and ALb<3 gr/dl)

排除标准

  • 未提供

研究者

相似试验

Assessment of Colchicine efficacy in treatment of... | 临床试验